These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31649250)

  • 1. Nogo receptor-vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme.
    Kang YH; Han SR; Jeon H; Lee S; Lee J; Yoo SM; Park JB; Park MJ; Kim JT; Lee HG; Lee MS; Lee SH
    Exp Mol Med; 2019 Oct; 51(10):1-15. PubMed ID: 31649250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.
    Kamil M; Shinsato Y; Higa N; Hirano T; Idogawa M; Takajo T; Minami K; Shimokawa M; Yamamoto M; Kawahara K; Yonezawa H; Hirano H; Furukawa T; Yoshimoto K; Arita K
    Br J Cancer; 2019 Apr; 120(8):819-826. PubMed ID: 30867563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference suppression of Nogo-66 receptor prevents Nogo-66-mediated inhibition of invasion and adhesion and simultaneously increases cell apoptosis in C6 cells.
    Tong S; Xiong N; Shen J
    Oncol Rep; 2013 Nov; 30(5):2171-8. PubMed ID: 23982337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
    Louca M; Zaravinos A; Stylianopoulos T; Gkretsi V
    Mol Cell Biochem; 2020 Aug; 471(1-2):143-153. PubMed ID: 32506247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
    Bhatia S; Bukkapatnam S; Van Court B; Phan A; Oweida A; Gadwa J; Mueller AC; Piper M; Darragh L; Nguyen D; Gilani A; Knitz M; Bickett T; Green A; Venkataraman S; Vibhakar R; Cittelly D; Karam SD
    Mol Carcinog; 2020 Sep; 59(9):1064-1075. PubMed ID: 32567728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Ras-Related Protein 25 (Rab25) Inhibits the In Vitro Cytotoxicity and In Vivo Antitumor Activity of Human Glioblastoma Multiforme Cells.
    Ding B; Cui B; Gao M; Li Z; Xu C; Fan S; He W
    Oncol Res; 2017 Mar; 25(3):331-340. PubMed ID: 28281975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
    Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
    Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B4GALT3 promotes cell proliferation and invasion in glioblastoma.
    Wu T; Li Y; Chen B
    Neurol Res; 2020 Jun; 42(6):463-470. PubMed ID: 32202233
    [No Abstract]   [Full Text] [Related]  

  • 12. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling.
    Liu B; Liu Y; Jiang Y
    Oncol Rep; 2015 May; 33(5):2583-91. PubMed ID: 25708368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
    Yue S; Wang L; Zhang H; Min Y; Lou Y; Sun H; Jiang Y; Zhang W; Liang A; Guo Y; Chen P; Lv G; Wang L; Zong Q; Li Y
    Tumour Biol; 2015 Sep; 36(9):6741-9. PubMed ID: 25833697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
    Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
    Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene.
    Huang YK; Su YF; Lieu AS; Loh JK; Li CY; Wu CH; Kuo KL; Lin CL
    Neurosci Lett; 2020 Oct; 737():135289. PubMed ID: 32791096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-148-3p Inhibits Growth of Glioblastoma Targeting DNA Methyltransferase-1 (DNMT1).
    Li Y; Chen F; Chu J; Wu C; Li Y; Li H; Ma H
    Oncol Res; 2019 Aug; 27(8):911-921. PubMed ID: 30982493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-Binding Motif Protein RBM47 Promotes Invasiveness of Glioblastoma Through Activation of Epithelial-to-Mesenchymal Transition Program.
    Xing YQ; Zhu TZ
    Genet Test Mol Biomarkers; 2023 Dec; 27(12):384-392. PubMed ID: 38156907
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.